Clinical Summary (Reconstructed from Your Description)

Differential Diagnoses for the New Epigastric Pain + Vomiting

1. ACUTE PANCREATITIS - Most Likely Drug-Induced

• Octreotide is a known (though rare) cause of acute pancreatitis - it can occur within the first hours to days of starting an infusion. This is well-documented in product literature. The Canadian product monograph explicitly states: "Acute pancreatitis has been reported within the first hours or days of octreotide."
• The mechanism: octreotide causes biliary sludge, increases bile lithogenicity, and can trigger sphincter of Oddi dysfunction leading to pancreatic ductal hypertension.
• USG can be normal in early acute pancreatitis (sensitivity of USG is only ~60-70% in early disease). CT abdomen with contrast is the gold standard.
• Workup: Serum amylase + lipase (3x ULN = diagnostic), urgent CECT abdomen.

2. ACUTE ACALCULOUS CHOLECYSTITIS

• Octreotide markedly inhibits gallbladder contractility and reduces bile flow. This promotes gallbladder stasis and sludge formation - a well-established risk (27% gallstone rate, 24% sludge rate even on short-term use per drugs.com data).
• Acalculous cholecystitis can occur with bile stasis even without stones - and importantly, USG can be normal or near-normal early in acalculous disease.
• More common in critically ill, hospitalized patients.
• Workup: HIDA scan (most sensitive), repeat USG with wall thickness/Murphy's sign assessment, hepatobiliary CT.

3. ASCENDING CHOLANGITIS (Charcot's / Reynolds' Triad)

• The patient already has cholestatic jaundice with Tbili >20 and melena. Even though MRCP was normal initially, dynamic biliary obstruction (stone passing, stricture flare, biliary sludge post-octreotide) can cause ascending cholangitis.
• Octreotide itself has been associated with cholangitis in the literature.
• Epigastric/RUQ pain + jaundice already present + fever (if present) = Charcot's triad.
• Workup: Fever check, blood cultures, LFTs trend, WBC, repeat imaging, consider ERCP.

4. PPI-RELATED OR DRUG-INDUCED GASTROPARESIS / Severe Dysmotility

• High-dose IV PPIs can occasionally cause severe nausea/vomiting and epigastric discomfort.
• Less likely to cause "severe" pain but worth considering as a contributing factor.
• PPIs can mask a duodenal ulcer perforation by reducing acid - pain may be partially treated but obstruction or bleeding persists.

5. PERFORATED PEPTIC ULCER (Partial or Contained)

• The patient had melena, suggesting upper GI bleed - likely a pre-existing peptic ulcer.
• A contained microperforation or posterior perforation (pancreatic penetration) would cause severe epigastric pain but may have normal free gas on USG (especially posterior perforations).
• Normal USG does NOT rule out perforation - you need an erect CXR (free subdiaphragmatic air) or CT.
• Workup: Erect CXR, urgent CT abdomen with oral contrast.

6. SPHINCTER OF ODDI DYSFUNCTION (SOD) / FUNCTIONAL BILIARY PAIN

• Given normal MRCP, SOD is a reasonable underlying diagnosis. Octreotide can paradoxically worsen SOD by altering sphincter tone in some patients.
• Presents with recurrent biliary-type epigastric pain, elevated enzymes, normal imaging.

7. ISCHEMIC HEPATITIS / HEPATIC INFARCTION

• In a jaundiced patient with possible GI bleeding, hemodynamic instability could reduce hepatic perfusion.
• Octreotide causes splanchnic vasoconstriction - rarely, this can compromise hepatic arterial flow.
• Consider if transaminases suddenly spike.

8. REACTIVATION / WORSENING OF UNDERLYING HEPATIC PATHOLOGY

• Bilirubin >20 with normal MRCP suggests intrahepatic cholestasis (drug-induced liver injury, viral hepatitis, autoimmune hepatitis, acute alcoholic hepatitis, etc.).
• The original cause may be worsening (e.g., hepatitis flare).

Key Workup to Order RIGHT NOW

Clinical Bottom Line

• Drug-induced acute pancreatitis (octreotide, within 24 hrs)
• Drug-induced gallbladder stasis/acalculous cholecystitis (octreotide)
• Ascending cholangitis on background of cholestatic jaundice

Sources: Octreotide hepatobiliary adverse effects - LiverTox/NCBI | Octreotide pancreatitis product monograph | Yamada's Textbook of Gastroenterology, 7th ed. | Harrison's Principles of Internal Medicine, 22nd ed.

What MRCP Actually Detects - and What It Misses

MRCP's Core Strength: Biliary Tree Anatomy

• CBD stones (choledocholithiasis)
• Biliary strictures (benign or malignant)
• Bile duct dilatation
• Primary sclerosing cholangitis (PSC) - intrahepatic AND extrahepatic
• Choledochal cysts
• Pancreatic duct pathology

What MRCP CANNOT See - and Why a Normal MRCP Does NOT Rule Out Cholestasis

The Core Principle

MRCP rules out LARGE DUCT obstruction (extrahepatic + large intrahepatic ducts). A normal MRCP means the bile ducts are NOT dilated or obstructed - it says NOTHING about hepatocyte function, canalicular transport, or small duct disease.

Practical Implication for Your Patient

• Tbili >20, cholestatic pattern
• Normal MRCP - means no large duct obstruction
• Therefore the cause is almost certainly intrahepatic cholestasis

1. AMA (Anti-mitochondrial antibody) - for Primary Biliary Cholangitis
2. ANA, ASMA, IgG - for Autoimmune Hepatitis / AIH-PBC overlap
3. Drug history - DILI is one of the most common causes
4. LFT pattern - Hepatitic (high AST/ALT) vs pure cholestatic (high ALP/GGT)
5. Liver biopsy - if no cause found (gold standard for intrahepatic cholestasis)
6. pANCA, IgG4 - for PSC small duct disease, IgG4 cholangiopathy
7. Viral serology - Hep A/B/C/E, EBV, CMV

Anatomy of the Biliary Tree

Overview Diagram

1. Intrahepatic Bile Ducts

• Bile canaliculi (between hepatocytes)
• Canals of Hering (transition zone, connects canaliculi to bile ductules)
• Bile ductules / cholangioles (periportal)
• Interlobular bile ducts (run with portal triads)
• Segmental intrahepatic ducts - drain Couinaud segments I-VIII
• Right anterior sectoral duct (segments V, VIII) + Right posterior sectoral duct (segments VI, VII) → unite to form the Right hepatic duct
• Left hepatic duct (segments II, III, IV + caudate/segment I usually drains here)

• True bifurcation (right + left meet): ~60%
• Trifurcation (right anterior, right posterior, left all meet): ~12%
• Right sectoral duct crossing to join left hepatic duct: ~28%

2. Hepatic Ducts (at the Hilum)

• Shorter than the left (0.5-2.5 cm)
• Formed just below the porta hepatis (95% of cases)
• In 5%, the ducts join within liver substance

• Longer and more superficial than the right
• Greater propensity for dilatation in distal obstruction

• Formed by union of right + left hepatic ducts - usually ~1 cm below porta hepatis
• Length: 2-6.5 cm
• Diameter: ~4 mm
• Position: anterior to portal vein, to the right of the hepatic artery
• Lies in the hepatoduodenal ligament (free edge of lesser omentum)
• The confluence lies anterior to the right branch of the portal vein

3. Triangle of Calot (Hepatocystic Triangle)

• Superior border: hilum of the liver
• Right border: cystic duct
• Left border: common hepatic duct

• Right hepatic artery
• Cystic artery
• 90% of accessory hepatic ducts
• 95% of aberrant right hepatic arteries

4. Cystic Duct

• Arises from the neck of the gallbladder
• Length: 0.5-8 cm (highly variable)
• Lumen: 1-3 mm (occasionally up to 10 mm - allows stones to pass into CBD)
• Contains spiral valves of Heister (mucosal folds - no true valvular function but make cannulation difficult)
• Most commonly (70%) joins CHD directly on the right side

• A: Normal low junction with CHD
• B: Cystic duct adherent to CHD (parallel course)
• C: High junction
• D: Drains into right hepatic duct
• E: Long cystic duct joining behind the duodenum
• F: Absent cystic duct
• G: Crosses posterior to CHD, joins anteriorly
• H: Courses anterior to CHD, joins posteriorly

5. Common Bile Duct (CBD)

6. Junction with Pancreatic Duct - Ampulla of Vater

7. Gallbladder

• Pear-shaped reservoir, 7-10 cm long, capacity ~50 mL
• Parts: Fundus → Body → Infundibulum (Hartmann's pouch) → Neck → Cystic duct
• Lies in the gallbladder fossa on the inferior surface of the liver (segments IV/V)
• Hartmann's pouch is the dependent part of the infundibulum - where stones commonly lodge
• Blood supply: Cystic artery (usually from right hepatic artery, within Calot's triangle)
• The ducts of Luschka (subvesical ducts) run adjacent to the gallbladder fossa and can be injured during cholecystectomy, causing bile leaks

Clinical Correlations

Sources: Yamada's Textbook of Gastroenterology, 7th ed. | Schwartz's Principles of Surgery, 11th ed. | Grainger & Allison's Diagnostic Radiology | Sabiston Textbook of Surgery